Work

Phase I study of oral suberoylanilide hydroxamic acid (SAHA), a histone deacetylase inhibitor, in patients (pts) with advanced leukemias or myelodysplastic syndromes (MDS)

Year: 2004

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2004.22.14_suppl.3027

Authors: G. Garcia-Manero, J.-P. Issa, J. Cortes, C. Koller, S. O'brien, E. Estey, A. A. Canalli, J. Chiao, V. Richon, H. Kantarjian

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Histone Deacetylase Inhibitors Research

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W86464820

Cites:

Cited by: 15

Related to: 10